ATE516013T1 - Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers - Google Patents

Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers

Info

Publication number
ATE516013T1
ATE516013T1 AT07863252T AT07863252T ATE516013T1 AT E516013 T1 ATE516013 T1 AT E516013T1 AT 07863252 T AT07863252 T AT 07863252T AT 07863252 T AT07863252 T AT 07863252T AT E516013 T1 ATE516013 T1 AT E516013T1
Authority
AT
Austria
Prior art keywords
reaction product
water
soluble reaction
gastroretentive composition
component
Prior art date
Application number
AT07863252T
Other languages
English (en)
Inventor
Shaukat Ali
Carlos Santos
Anisul Quadir
Original Assignee
Basf Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Corp filed Critical Basf Corp
Application granted granted Critical
Publication of ATE516013T1 publication Critical patent/ATE516013T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
AT07863252T 2007-07-06 2007-12-26 Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers ATE516013T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94821607P 2007-07-06 2007-07-06
PCT/US2007/026347 WO2009008873A1 (en) 2007-07-06 2007-12-26 A gastroretentive composition on the basis of a water-soluble reaction product from a vinyl group- containing precursor

Publications (1)

Publication Number Publication Date
ATE516013T1 true ATE516013T1 (de) 2011-07-15

Family

ID=39361424

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07863252T ATE516013T1 (de) 2007-07-06 2007-12-26 Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers

Country Status (5)

Country Link
US (1) US9622966B2 (de)
EP (1) EP2182917B1 (de)
AT (1) ATE516013T1 (de)
ES (1) ES2368356T3 (de)
WO (1) WO2009008873A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2133071A1 (de) * 2008-06-09 2009-12-16 Université de la Méditerranée Verfahren zur Herstellung gastroretentiver Darreichungsformen
PT2498801T (pt) 2009-11-13 2018-05-02 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendin-4(1-39)-lys6-nh2 e metionina
CA2951905A1 (en) * 2014-06-12 2015-12-17 Orbis Biosciences, Inc. Extended-release drug delivery compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2930762A (en) * 1957-08-08 1960-03-29 Universal Oil Prod Co Polyvinyl compounds as lubricants in pilling operations
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
AU2003299838A1 (en) 2002-12-19 2004-07-14 Polymorfix, Inc. Ingestible formulations for transient, noninvasive reduction of gastric volume
US20040208931A1 (en) * 2002-12-30 2004-10-21 Friend David R Fast dissolving films for oral administration of drugs
US20050019400A1 (en) * 2003-01-27 2005-01-27 Deveney Thomas William Controlled-release drug delivery system
JP2006076971A (ja) * 2004-09-13 2006-03-23 Basf Ag 口腔内崩壊錠

Also Published As

Publication number Publication date
EP2182917B1 (de) 2011-07-13
EP2182917A1 (de) 2010-05-12
WO2009008873A1 (en) 2009-01-15
ES2368356T3 (es) 2011-11-16
US20120269866A1 (en) 2012-10-25
US9622966B2 (en) 2017-04-18

Similar Documents

Publication Publication Date Title
MX2019001169A (es) Formulacion novedosa para administracion por via oral.
MX2009004707A (es) Piridina carboxamides como inhibidores 11-beta-hsd1.
BR112012015318A2 (pt) Material autossustentável, composição, artigo de fabricação e uso de um material autossustentável
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
MX2010004292A (es) Producto de dispersion solida que contiene un compuesto a base de n-aril urea.
EA201071218A1 (ru) Улучшенные композиции для активных фармацевтических компонентов с плохой проницаемостью
DK2178513T3 (da) Sammensætninger i tabletform indeholdende atazanavir
EA200900572A1 (ru) Мицеллярные наночастицы с химическими субстанциями
MX2019009071A (es) Celulas microbianas, metodos para producir las mismas, y usos de las mismas.
WO2018152320A8 (en) Systems and methods for the fabrication of tablets, including pharmaceutical tablets
ATE499927T1 (de) Tablettierte atazanavirhaltige zusammensetzungen
ATE516013T1 (de) Gastroretentive zusammensetzung auf basis eines wasserlöslichen reaktionsprodukts eines vinylgruppen enthaltenden vorläufers
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
MX2010004291A (es) Producto de dispersion solida de farmacos basados en n-aril urea.
WO2008069938A3 (en) Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide
MX2016008527A (es) Preparaciones solidas que contienen tofogliflozina y proceso para producir las mismas.
EP2946671A3 (de) Hydrophile kaugummigrundmasse
JP2013523834A5 (de)
RU2013154972A (ru) Способ изготовления порошков для ингаляции
DE602008005462D1 (de) Tablettierte atazanavirhaltige zusammensetzungen
WO2008021875A3 (en) Pharmaceutical tablets containing a plurality of active segments
CO6390098A2 (es) Formulaciones de desintegración rapida pre-compactadas de compuestos con baja biodisponibilidad oral.
MX2022012239A (es) Compuestos de amida y usos de los mismos.
TW200621224A (en) Pharmaceutical composition
RU2015109274A (ru) Основа жевательной резинки и способ получения жевательной резинки

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties